Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 9 results for "zenotech labs"

Zenotech Labs hits upper limit verdict for open offer
India Infoline

Zenotech Labs hits upper limit verdict for open offer

The stock is locked at the 2 percent upper circuit at Rs. 35.70 on the BSE. Zenotech Laboratories has hit the 2 percent upper limit at Rs. 35.70 on likelihood of the Sun Pharma open offer going through. According to a release issued by the company to the BSE, ... India Infoline, 1 week ago
Zenotech Lab gains 2% after open offer 'fair' India Infoline, 1 week ago
[x]  

2 images for "zenotech labs"

India Infoline, 1 week ago
Business Standard, 1 month ago

Sensex slips over 150 points, Nifty below 8400, Mastek surges 18%

NEW DELHI: The S&P BSE Sensex slipped over 100 points after starting on a cautious note on Friday, tracking Asian markets which were trading with a negative bias as Greece failed again to reach an agreement with its creditors and stumbled towards a ...
 Economic Times1 week ago

Daily Market Strategy - Flat start; swings in store

Just celebrate the life you had, not the life you could've had - Magic Johnson As the NDA government led by BJP's Narendra Modi completes one year in office, most CEOs acknowledge the reforms undertaken and initiatives done to reduce corruption ...
 India Infoline1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less